UNIVERSITE DE TOURS

Their core work

Université de Tours is a French public university with research strengths spanning power electronics, biomedical sciences, cultural heritage, and environmental modelling. Their H2020 portfolio reveals active labs working on wide-bandgap semiconductor materials (SiC and GaN) for energy-efficient power conversion, drug-resistant pneumonia therapies using innate immunity pathways, and AI-driven water-energy-food nexus modelling. They also maintain a distinct humanities research capability in historical musicology and cultural economics, an unusual combination for a mid-sized French university.

What they specialise in

How they've shifted over time

In the early period (2016-2019), Tours focused on IoT energy harvesting, wide-bandgap semiconductors (SiC), hyperpolarized MR imaging, and pediatric brain stimulation — a mix of electronics and biomedical research. From 2020 onward, the university shifted toward GaN-based power electronics for automotive and industrial applications, innate immunity therapies for antimicrobial resistance, AI-driven environmental modelling, and deepened its cultural heritage work. The clearest trend is a convergence on applied power electronics and a growing health portfolio around infectious disease, while the humanities line has matured into coordinated projects.

Tours is building toward applied GaN power conversion for automotive and renewables while expanding into antimicrobial resistance therapies — two high-demand fields for future EU funding calls.

How they like to work

Tours predominantly joins projects as a participant (8 of 13 projects), with 3 third-party roles and only 2 as coordinator — both in humanities. Their 241 unique partners across 35 countries indicate a broad, well-connected network rather than a tight cluster of repeat collaborators. This profile suggests a reliable consortium partner who brings specialized expertise to large multi-partner projects rather than driving the overall project agenda.

With 241 unique consortium partners across 35 countries, Tours has an extensive European network. Their collaborations span Western and Southern Europe heavily, with no visible geographic concentration beyond France.

What sets them apart

Tours stands out for its rare combination of hard-science power electronics research and deep humanities scholarship within the same H2020 portfolio — few universities bridge GaN semiconductors and historical soundscapes. Their microbial biotechnology work on therapeutic alkaloids (MIAMi, their largest single grant) signals strong biochemistry capabilities that complement the electronics and health lines. For consortium builders, Tours offers a genuinely multidisciplinary partner that can contribute technical depth in power electronics or life sciences while also covering social science and cultural heritage dimensions often needed in cross-cutting EU calls.

Highlights from their portfolio

• MIAMi
  Largest single grant (EUR 1.27M) for refactoring alkaloid production in yeast — signals strong microbial biotechnology capability.
• GaN4AP
  Directly continues WInSiC4AP's wide-bandgap work but with GaN for automotive and industrial power conversion — shows sustained commitment to this field.
• FAIR
  Phase I clinical trial for flagellin aerosol therapy against drug-resistant pneumonia — a translational health project addressing the critical antimicrobial resistance challenge.